Advanced search
Publication Cover
Platelets Volume 14, 2003 - Issue 5
Submit an article Journal homepage
55
Views
27
CrossRef citations to date
0
Altmetric
Research Article

Mean platelet volume as an indicator of platelet activation: methodological issues

I. Anita Jagroop Royal Free and University College Medical School (University of London), Royal Free Hospital, Campus Pond Street, London, NW3 2QG, UK
,
Stavroula Tsiara Royal Free and University College Medical School (University of London), Royal Free Hospital, Campus Pond Street, London, NW3 2QG, UK
&
Dimitri P. Mikhailidis Royal Free and University College Medical School (University of London), Royal Free Hospital, Campus Pond Street, London, NW3 2QG, UK
Pages 335-336 | Published online: 21 Jun 2011

References

  • Park Y. Schoene N, Harris W. Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets 2005; 13: 301 6.
  • Endler G, Klimesch A. Sunder-Plassmann H, et aí. Mean Plaielei Volume is an independem risk factor for myocardial infarction bul not for coronary artery disease. Br J Haematol 2002; 117: 399–404.
  • Tsehopc D. Langer E, Schauseil S. Rosen P. Kaufmann L, Grics FA. Increased platelet volume - sign of impaired ihrombopoiesis in diabetes mellitus. Klin Woclwnshr 1989; 67: 253–9.
  • Kano K, Matsuo T, Nakao K. Cigarette smoking increases the mean platelet volume in elderly patients with risk of atherosclerosis. Clin Lab Haematol 1992: 14: 281–7.
  • Gladwin A M. Malin J F, The control of megakaryocyte ploidy and platelet production: biology and pathology. Intern J Cell Cloning 1990:8:291-8.
  • Barradas M A- OTJonoghuc S. Mikhailidis D P. Measure mem of platelet volume using a channclyzcr: Assessment of the effect of agonists and antagonists. /// vivo. 1992; 6: 629–34.
  • Barradas M A. Jagroop I A, O’Ponoghue S, Jeremy J Y. Mikhailidis D P. Effect of milrinone on human platelet shape change, aggregation and thromboxane A¿ synthesis: an in vitro study. Thromb Res 1993: 71: 227 36.
  • Jagroop I A. Barradas M A. Mikhailidis D P. A low molecular weight heparin, nadroparin (Frax ¡parine). inhibits thrombin induced platelet shape change and does not enhance spontaneous platelet aggregation, fíf J Clin Pharmacol 1996; 41; 163–5.
  • Jagroop I A. Gatworlhy I, Lewin J, Mikhailidis D P Shape change on human platelets-measurements with a channely/er and visualisation by electron microscopy. Piateteli 2000; 11: 28–32.
  • Jagroop 1 A. Mikhailidis D P. An investigation of the serotonergic effects of fenfluramine, dexfenfluramine and dexnorfenfl ura mine using platelets as neuronal models. Platelets 2000; U:\bl-S.
  • Jagroop I A, Mikhailidis D 1*. Angiotensin II can induce and potentiate shape change in human platelets: effect of losartan. J Human Hypertens 2000; 14; 581–5.
  • Jagroop I A. Mikhailidis D P. Doxazosin a selective ai-adrenoceptor antagonist, inhibits scrotonin-mduced shape change in human platelets. J Human Hypertens 2001: 15: 203- 7.
  • Jagroop I A. Mikhailidis D P. Effect of cndotheiln-l on human plaielei shape chance: reversal of activation by naftidrofuryl. Platelets 2000; 11: 277–82.
  • Mikhailidis D P, Barradas M A, O’Donoghuc S. Dandona P. Evidence form vivo platelet activation following the injection of conventional unfractionaied heparin. Platelets 1990; 1: 189–92.
  • Nystrom M L. Barradas M A. Jeremy J Y. Mikhailidis D P. Platelet shape change in whole blood: differential effects of endotoxin. Tlmmib Haemost 1994; 71: 646–50.
  • Jagroop I A. Burnstock G, Mikhailidis D P. Both the ADP receptors. P2Yt and P2Yi;, play a role in controlling shape change in humans platelets. Platelets 2003; 14(1): 15–20.
  • Barradas M A. Stansby G. Hamilton Ci, et al. Diminished platelet yield and enhanced platelet aggregability in platelet-rich plasma of peripheral vascular disease patients. Int Angiol 1994; 13:202–7.
  • Barradas M A. Stansby G. Hamilton G, Mikhailidis D P. Effect of naftidrofuryl and aspirin on platelet aggregation in peripheral disease. /;; vivo 1993; 7: 543–8.
  • Yusul S, Zhao F. Metha S R. et ai The Clopidogrel in Unstable angina to prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segmeni elevation. JV Engl J Metl 2001; 345:494–502.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.